Form 4: Quanterix CEO Granted 1.88M RSUs

Quanterix Corporation's President and CEO, Everett Cunningham, was granted 1,883,750 restricted stock units, aligning his incentives with shareholder value.

Summary

• Everett Cunningham, President and CEO, and a Director of Quanterix Corp (QTRX), was granted a total of 1,883,750 Restricted Stock Units (RSUs).
• This grant occurred on January 19, 2026.
• The grant includes 813,750 performance-based RSUs, which vest if the company's common stock volume-weighted average price meets specific thresholds within a four-year period.
• Additionally, 1,070,000 time-based RSUs were granted, vesting in equal one-fourth installments annually on January 19, 2027, 2028, 2029, and 2030.
• Each RSU represents a contingent right to receive one share of Quanterix's common stock.
• The vesting conditions are further detailed in the Employment Agreement between the Issuer and Mr. Cunningham, dated January 8, 2026.

Sentiment

Score: 7

Explanation: The grant of significant equity awards to the CEO is generally positive as it aligns management's interests with shareholders and incentivizes long-term performance. However, it also implies future dilution.

Positives

• The grant of a significant number of RSUs to the President and CEO, Everett Cunningham, aligns his long-term incentives directly with the company's stock performance and shareholder value creation.
• The inclusion of performance-based RSUs (813,750 units) ties a substantial portion of his compensation to specific stock price achievements, indicating a focus on market-driven success.
• The time-based RSUs (1,070,000 units) provide a retention mechanism, ensuring the CEO's continued commitment over a four-year vesting period.

Negatives

• The future conversion of these 1,883,750 RSUs into common stock will result in dilution for existing shareholders.

Risks

• The performance-based RSUs are contingent on the company's stock price meeting certain thresholds, meaning the CEO may not fully realize the value of these units if performance targets are not met.
• The value of both performance-based and time-based RSUs is directly tied to the future market price of Quanterix common stock, exposing the CEO's compensation to market fluctuations.

Future Outlook

The grant of performance-based and time-based restricted stock units indicates a long-term incentive structure for the CEO, aligning future compensation with the company's stock performance and continued service through January 2030.

Industry Context

This RSU grant is a standard practice in executive compensation within the biotechnology and life sciences industry, aiming to incentivize long-term leadership and align executive interests with shareholder returns. Companies often use a mix of time-based and performance-based equity awards to balance retention with performance achievement.

Related Party Transactions

• The grant of 1,883,750 Restricted Stock Units to Everett Cunningham, the President and CEO and a Director, constitutes a transaction with a related party, as is standard for executive compensation arrangements.

Stakeholder Impact

• Shareholders: Potential future dilution upon vesting and conversion of RSUs into common stock. Increased alignment of CEO's interests with shareholder value.
• Employees: May signal stability in leadership and a long-term strategic vision.
• Management: Provides significant long-term incentive and compensation tied to company performance and tenure.

Next Steps

• Vesting of time-based RSUs on January 19, 2027, 2028, 2029, and 2030.
• Potential vesting of performance-based RSUs if stock price thresholds are met within the four-year period ending January 20, 2030.

Key Dates

Keywords

Quanterix, QTRX, Everett Cunningham, Restricted Stock Units, RSU, Insider Transaction, CEO Compensation, Equity Grant, Performance-Based RSU, Time-Based RSU, SEC Form 4